Bionic Pancreas in CFRD

Recruiting now · Phase 3

Conditions studied: Cystic Fibrosis-related Diabetes

In brief

This multi-center randomized controlled trial (RCT) will compare efficacy and safety endpoints using the insulin-only configuration of the iLet Bionic Pancreas System (BP) versus a control group using their usual care insulin delivery method and continuous glucose monitoring (CGM) during a 13-week study period in individuals ≥14 years old with cystic fibrosis-related diabetes (CFRD). After 13 weeks, participants will continue in a 13-week Extension Phase in which the BP group will continue to use the BP system and the Usual Care group will initiate use of the BP system.

Key facts

Study ID
NCT06449677
Run by
Jaeb Center for Health Research
People needed
150
Starts
2024-09-24
Expected to finish
2027-03-30
Last updated by the study team
2026-06-24

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.